Proton therapy for lymphoma in the chest
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests proton therapy, a precise type of radiation, to treat lymphoma in the chest. The goal is to reduce damage to healthy organs while still curing the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have Hodgkin or non-Hodgkin lymphoma confirmed by biopsy.
- Your lymphoma is limited to the chest, and may also be in the neck or underarms.
- You are planning to have treatment that is meant to be curative.
- You are willing to sign a consent form agreeing to participate.
- You have not had radiation therapy to the chest in the past.
- You do not have another active cancer.
- You are able to attend all radiation sessions and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about adults with lymphoma who need treatment that targets the chest/mediastinum. It focuses on how proton radiation may help protect the heart, lungs, and breast compared with the more common photon radiation.
This trial studies the effects of radiation therapy on the chest area (mediastinum) in patients with lymphoma or thymoma. It aims to see how well modern radiation works after chemotherapy and may help improve treatment outcomes.
This trial tests if proton beam radiation can effectively treat Hodgkin lymphoma while reducing side effects. It is for people with early-stage disease who have already completed chemotherapy and need radiation.
This study tests proton beam radiation for people with liver cancer that is still inside the liver but cannot be treated with surgery or a small-needle procedure. Proton beams aim to better target the tumor while reducing radiation to nearby organs.
This trial tests proton radiation to treat cancer that has spread into the thin lining around the brain and/or spinal cord (leptomeningeal metastasis). It may help control disease in that area while aiming to better protect surrounding healthy tissue.
This trial studies proton radiotherapy (a type of radiation) for cancers of the thymus, like thymoma or thymic carcinoma. It may help improve tumor control while limiting radiation exposure to nearby organs.
Hear when a new Mediastinal Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.